Skip NavigationSkip to Content
Return Return to Search Results

Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway

  1. Author:
    Chie, L.
    Amar, S.
    Kung, H. F.
    Lin, M. C. M.
    Chen, H.
    Chung, D. L.
    Adler, V.
    Ronai, Z.
    Friedman, F. K.
    Robinson, R. C.
    Kovac, C.
    Brandt-Rauf, P. W.
    Yamaizumi, Z.
    Michl, J.
    Pincus, M. R.

  2. Author Address

    Pincus MR Vet Adm Med Ctr, Dept Pathol & Lab Med 800 Poly Pl Brooklyn, NY 11209 USA Vet Adm Med Ctr, Dept Pathol & Lab Med Brooklyn, NY 11209 USA Long Isl Univ, Dept Biol Brooklyn, NY 11201 USA Long Isl Univ, Dept Chem Brooklyn, NY 11201 USA NCI, Lab Biochem Physiol Frederick, MD 21702 USA CUNY, Mt Sinai Med Ctr, Ruttenberg Canc Ctr New York, NY 10029 USA NCI, Mol Carcinogenesis Lab, NIH Bethesda, MD 20892 USA Columbia Univ, Sch Publ Hlth, Div Environm Hlth Sci New York, NY 10032 USA NCI Tokyo Japan SUNY Hlth Sci Ctr, Dept Pathol Brooklyn, NY 11203 USA Dept Microbiol Brooklyn, NY USA Dept Anat & Cell Biol Brooklyn, NY USA
    1. Year: 2000
  2. Journal: Cancer Chemotherapy and Pharmacology
    1. 45
    2. 6
    3. Pages: 441-449
  4. Type of Article: Article
  1. Abstract:

    Purpose: We have previously found that microinjection of activated MEK (mitogen activated kinase kinase) and ERK (mitogen-activated protein; MAP kinase) fails to induce oocyte maturation, but that maturation, induced by oncogenic ras-p21 and insulin-activated cell ras-p21, is blocked by peptides from the ras-binding domain of raf. We also found that jun kinase (JNK), on the stress-activated protein (SAP) pathway, which is critical to the oncogenic ras-p21 signal transduction pathway, is a strong inducer of oocyte maturation. Our purpose in this study was to determine the role of the raf-MEK-MAP kinase pathway in oocyte maturation and how it interacts with JNK from the SAP pathway. Methods: We microinjected raf dominant negative mutant mRNA (DN-raf) and the MEK-specific phosphatase, MKP-T4, either together with oncogenic p21 or c-raf mRNA, into oocytes or into oocytes incubated with insulin to determine the effects of these raf-MEK-MAP kinase pathway inhibitors. Results: We found that oocyte maturation induced by both oncogenic and activated normal p21 is inhibited by both DN-raf and by MKP-T4. The latter more strongly blocks the oncogenic pathway. Also an mRNA encoding a constitutively activated MEK strongly induces oocyte maturation that is not inhibited by DN-raf or by MKP-T4. Surprisingly, we found that oocyte maturation induced by JNK is blocked both by DN-raf and MKP-T4. Furthermore, we discovered that c-raf induces oocyte maturation that is inhibited by glutathione-S-transferase (GST), which we have found to be a potent and selective inhibitor of JNK. Conclusion: We conclude that there is a strong reciprocal interaction between the SAP pathway involving JNK and the raf-MEK-MAP kinase pathway and that oncogenic ras-p21 can be preferentially inhibited by MEK inhibitors. The results imply that blockade of both MEK and JNK-oncogenic ras-p21 interactions may constitute selective synergistic combination chemotherapy against oncogenic ras-induced tumors. [References: 35]

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel